Trial Profile
Genotype Stratified Treatment With Anticholinergic vs. [versus] Beta-Agonist (Long Acting) and Exacerbations (GABLE)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Corticosteroids; Formoterol; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms GABLE
- 21 Mar 2012 Actual patient number is 355 according to ClinicalTrials.gov.
- 21 Mar 2012 Planned end date changed from 1 Aug 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
- 21 Mar 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.